Nuclear Energy Research Initiative (NERI) Final Scientific/Technical Report “Developing Improved Structural Materials using Proton Irradiation as a Rapid Analysis Tool” Project IWO # M2SF 02-110 Project No. 99-0155 Submitted by: Lead Organization: Argonne National Laboratory

Production of Holmium-166 DOTMP: A promising agent for bone marrow ablation in hematologic malignancies

  Intoduction: Therapeutic radiopharmaceuticals are radiolabeled molecules to deliver sufficient doses of ionizing radiation to specific disease sites such as bone metastases, brain and liver tumors and bone marrows malignancies including multiple myeloma. Among some therapeutic radiopharmaceuticals, 166Ho-1,4,7,10 -tetraazacyclo dodecane-1,4,7,10 tetraethy...

Report of national training course on “Medical preparedness and response to radiation emergencies”, 2-6 Oct. 2004, Tehran, Iran

During the past years, special emphasis was put on medical preparedness in the event of radiological or nuclear emergencies. Novin Medical Radiation Institute (NMRI) encouraged and supported the national authorities to enhance their cooperation in improving medical response to radiation accident. NMRI in cooperation with International Atomic Energy Agency (IAEA) and Atomic Energy Organization o...

Neri Project 99-119. Task 2. Data-driven Prediction of Process Variables. Final Report

CCS Activities Being Performed by the U.S. DOE

The United States Department of Energy (DOE) is the lead federal agency for the development and deployment of carbon sequestration technologies. Its mission includes promoting scientific and technological innovations and transfer of knowledge for safe and permanent storage of CO(2) in the subsurface. To accomplish its mission, DOE is characterizing and classifying potential geologic storage res...

Development of Sm-153 chitosan for radiosynovectomy

  Introduction: Developing new radiosynovectomy agents is of great importance due to the aging of human populations around the world and increasing the incidence of inflammatory diseases. In this work, Sm-153 chitosan agent was developed for the first time in our country and preparation and quality control of the compound is described. Methods: Sm-153 chloride was ob...